PRPO logo.png
Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™
August 20, 2020 13:00 ET | Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS...
PRPO logo.png
Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
June 04, 2019 09:10 ET | Precipio, Inc.
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing...
PRPO logo.png
Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory
May 06, 2019 09:20 ET | Precipio, Inc.
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it is in the process of completing a trial of its Proprietary IV-Cell...